Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian(Mayo Clinic), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Michael A. O’Donnell(University of Iowa Health Care), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Daniel Canter(Ochsner Medical Center), Paul L. Crispen(University of Kentucky), Gennady Bratslavsky(SUNY Upstate Medical University), Tracy M. Downs(University of Wisconsin–Madison), Alan Boyd(University of Edinburgh), Seppo Ylä‐Herttuala(University of Eastern Finland), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Brian R. Lane(Grand Rapids Community College), Michael B. Williams(Eastern Virginia Medical School), Lawrence I. Karsh(The Urology Center of Colorado), Joseph Mashni(The University of Texas MD Anderson Cancer Center), Adam Luchey(West Virginia University), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Yair Lotan(Southwestern Medical Center), Nigel Parker(University of Eastern Finland), Tracey L. Krupski(University of Virginia Cancer Center), Seth P. Lerner(Baylor College of Medicine), Brant A. Inman(Duke Medical Center), Michael S. Cookson(University of Oklahoma Health Sciences Center), Gary D. Steinberg(Rush University Medical Center), Gordon Brown(New Jersey Urology), Badrinath R. Konety(Allina Health), Ruth Coll(Parker Hannifin (United Kingdom)), Anne Schuckman(University of Southern California), Vikram M. Narayan(Emory University), Michael Woods(University of Cambridge), Leonard G. Gomella(Thomas Jefferson University), Trinity J. Bivalacqua(University of Pennsylvania), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Michael Poch(Moffitt Cancer Center), Neal D. Shore(Carolina Urologic Research Center), F. Peter Treasure(Royal Statistical Society), Kirk A. Keegan(Vanderbilt University Medical Center), Joseph E. Busby(Prisma Health), Alexander I. Sankin(Montefiore Medical Center), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Richard Philipson(Parker Hannifin (United Kingdom)), Mehrdad Alemozaffar(Kaiser Permanente), David G. Sawutz
The Lancet Oncology
November 27, 2020
Cited by 459


Related Papers